Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Cloud over AZ cancer drug

Posted 26 February 2021 AM

Uncertainty surrounds the bladder cancer indication for AstraZeneca's Imfinzi in Australia after the company withdrew its use in the US earlier this week.

In a global statement on Monday, the company revealed it had decided to "voluntarily" withdraw Imfinzi's indication for previously treated locally advanced or metastatic bladder cancer after a pivotal trial did not meet its primary endpoints in the US.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas